Filing Details
- Accession Number:
- 0001179110-15-010090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-19 17:18:22
- Reporting Period:
- 2015-06-18
- Filing Date:
- 2015-06-19
- Accepted Time:
- 2015-06-19 17:18:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579003 | Steven Allan Jacobson | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-06-18 | 5,000 | $50.13 | 6,848 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $51.00 | 2016-01-02 | 2025-01-01 | 12,000 | 12,000 | Direct |
Common Stock | Stock Option (right to buy) | $27.05 | 2015-01-28 | 2024-01-27 | 10,000 | 10,000 | Direct |
Common Stock | Stock Option (right to buy) | $10.85 | 2023-05-15 | 63,000 | 63,000 | Direct | |
Common Stock | Stock Option (right to buy) | $218.40 | 2022-01-10 | 83 | 83 | Direct | |
Common Stock | Stock Option (right to buy) | $490.80 | 2021-04-27 | 250 | 250 | Direct | |
Common Stock | Stock Option (right to buy) | $1,149.60 | 2020-02-02 | 83 | 83 | Direct | |
Common Stock | Stock Option (right to buy) | $508.80 | 2019-10-07 | 83 | 83 | Direct | |
Common Stock | Stock Option (right to buy) | $626.40 | 2007-04-18 | 83 | 83 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2025-01-01 | 12,000 | 12,000 | Direct |
2024-01-27 | 10,000 | 10,000 | Direct |
2023-05-15 | 63,000 | 63,000 | Direct |
2022-01-10 | 83 | 83 | Direct |
2021-04-27 | 250 | 250 | Direct |
2020-02-02 | 83 | 83 | Direct |
2019-10-07 | 83 | 83 | Direct |
2007-04-18 | 83 | 83 | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $49.89 to $50.36 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.
- Currently exercisable.